Current Status of Immunosuppressive Therapy in Renal Transplantation
Year: 2025
Type: article
Abstract: For individuals with end-stage renal disease, kidney transplantation remains the leading treatment choice, offering significant benefits in terms of survival and life satisfaction. However, long-term graft survival is challenged by acute and chronic rejection, drug toxicity, infections, and malignancies. Traditional immunosuppressive regimens, including calcineurin inhibitors, antimetabolites, corticosteroids, and mTOR inhibitors, have significantly improved short-term outcomes but are associated with serious side effects. Recent advancements in immunosuppressive therapy focus on novel strategies such as co-stimulation blockers, protein kinase C inhibitors, JAK-STAT inhibitors, complement inhibitors, and regulatory T-cell therapies. Additionally, precision medicine approaches, including biomarker-guided immunosuppression and pharmacogenomics, are being explored to optimize therapy while minimizing adverse effects. This review outlines current immunosuppressive approaches and emerging therapies, highlighting how these drugs modulate immune system activity in renal transplant recipients. It also discusses the complications linked to immunosuppressive treatment, with an emphasis on enhancing long-term graft survival and patient outcomes.
Author: Mubasira V, Manju C S*
Language: English
Subfield: Transplantation
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W7082630571
FWCI:
Cites:
Cited by:
Related to: